Applications of 2-Phenyl-1,3-Thiazolane-4-Carboxylic Acid in Industrial Manufacturing

2-Phenyl-1,3-Thiazolane-4-Carboxylic Acid supports advanced chemical synthesis in several B2B sectors. Our focus as a primary manufacturer is on precise quality management and process control from raw material handling to end-product delivery. Below, we detail real-world industrial uses with specific compliance, process, and formulation details.

1. Pharmaceutical Intermediates for Beta-Lactam Antibiotic Synthesis

This compound enters the pharmaceutical production chain as a chiral building block, particularly in beta-lactam antibiotic synthesis. Production facilities utilize its heterocyclic core to construct side chains required for third-generation cephalosporins and carbapenems. The input material must meet high-purity specifications to ensure downstream stereochemical integrity. Customers request defined enantiomeric excess and low residual solvent concentrations due to regulatory submissions. Technical teams optimize reaction yields through in-process QC and tailored solvent systems.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• USP <941> Chromatography Methods
• European Pharmacopoeia 2.2.46 (Chiral analysis)
• 21 CFR Part 211 (US FDA cGMP for finished pharmaceuticals)

Typical usage ratio

• 0.2–0.4 molar equivalents per antibiotic API batch
• Adjusted according to the side chain design and desired final chiral purity

Downstream process integration

• Enters amidation or acylation steps following cephalosporin or carbapenem core assembly
• Pre-dissolved in DMAc or DMSO prior to addition
• Monitored by HPLC and chiral assay during and after reaction

Final product types

• Third-generation cephalosporin APIs (e.g., cefdinir, cefixime)
• Carbapenem intermediates
• Finished injectable or oral antibiotics (after further processing)

2. Agrochemical Intermediate in Thiazole-Derived Fungicides

The thiazolane structure plays a functional role in the synthesis of fungicidal active ingredients for crop protection. Major agrochemical manufacturers incorporate this precursor into production of specific thiazole-based fungicides, where it enables precise structural modifications to target challenging fungal pathogens. QC laboratories test each batch for residual solvents, heavy metals, and identity as outlined in agrochemical development protocols, ensuring environmental and user safety for finished formulations.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• ISO 17025 for analytical testing
• Regulation (EC) No 1107/2009 (EU approval of active substances)
• SIN List (Substitute It Now!) for hazardous substances screening

Typical usage ratio

• 5–10% by mass in thiazole coupling reactions
• Optimized based on target fungicide molecular architecture

Downstream process integration

• Introduced during key heterocyclization or acylation stage
• Utilized as the limiting reagent in formation of thiazole rings
• Product isolated by crystallization after reaction completion

Final product types

• Thiazole-based fungicidal actives (e.g., members of the triazole and strobilurin groups)
• Emulsifiable concentrates for broad-acre crops
• Seed treatment agents

3. Advanced Material Synthesis for Specialty Polymer Additives

Polymer manufacturers in the engineering plastics sector value the heterocyclic functionality to produce thiazolane-functionalized monomers. These monomers provide enhanced chemical resistance or thermal stability to specialty polyamides and polyurethanes. The material typically undergoes amide bond formation or copolymerization with other monomer units using precise stoichiometric controls, where side reactions must be minimized. Our QA program encompasses elemental analysis, water content checks, and specification-driven release criteria.

Industry compliance standards

• ISO 9001 Quality Management for Material Manufacturing
• REACH (EC 1907/2006) Registration, Evaluation, Authorisation
• UL 94 Flammability Testing (where required for finished products)
• ASTM D638 (Mechanical properties, tensile test for plastics)

Typical usage ratio

• 1–3% by weight as a specialty monomer or additive in copolymerization reactors
• Ratio adjusted based on final performance requirements and chain propagation rates

Downstream process integration

• Dosed directly into polymerization reactors under controlled temperature
• Pre-tested for compatibility with standard comonomers (e.g., caprolactam for PA6 derivatives)
• Residual monomer stripped under vacuum during post-polymerization

Final product types

• Specialty polyamides and polyurethanes for electronics housings
• Antistatic and chemical-resistant plastics
• High-performance automotive polymer parts

4. Fine Chemical Intermediate for Chiral Ligand Manufacturing

Synthesis laboratories and specialty catalyst producers use the compound as a starting intermediate for crafting chiral ligands used in asymmetric catalysis. Its thiazolane core provides chelating sites for transition metals, vital in enantioselective hydrogenation and C–C coupling reactions. The starting material must arrive with low optical impurity and minimal metal catalyst residues, confirmed through advanced QC. Formulators adjust input ratios to match metal complexation yields and minimize costly by-products.

Industry compliance standards

• ISO 17034 Reference Material Producers accreditation
• OECD Good Laboratory Practice for analytical verification
• Purity ≥99% HPLC with specific optical rotation values
• Metal impurity limits as per customer specification sheets

Typical usage ratio

• 0.05–0.12 molar equivalents per ligand synthesis batch
• Adjusted by target ligand structure and metal loading requirements

Downstream process integration

• Introduced in the initial condensation or cyclization stage of ligand production
• Reaction monitored by TLC and NMR for intermediate conversion
• Unreacted material recovered and recycled when possible

Final product types

• Chiral bidentate ligands (e.g., for Rh, Ru, Pd catalysis)
• Homogeneous catalysts for bulk and fine chemical production
• Screening libraries for custom catalyst system development

5. Key Intermediate for API Impurity Reference Standard Preparation

Analytical labs and pharmaceutical QA departments incorporate this material to synthesize critical impurity reference standards required for process validation and regulatory filings. The defined thiazolane structure enables the creation of structurally similar impurities found in cephalosporin or thiazolyl antibiotic APIs. Production relies on batch-level documentation with impurity profiles and isotopic labeling when required. In-house analytical teams ensure the resulting materials support ICH and pharmacopoeial identification protocols.

Industry compliance standards

• ICH Q3A/B (Impurities in New Drug Substances and Products)
• USP, EP, JP compendial requirements for impurity standards
• ISO 17025: Calibration and testing lab accreditation
• US FDA and EMA impurity reporting protocols

Typical usage ratio

• 0.01–0.05 molar equivalents per reference standard synthesis batch
• Adjusted for desired isotope labeling and required purity

Downstream process integration

• Introduced during impurity structure synthesis, often via targeted alkylation or oxidation
• Intermediate isolated and purified by preparative HPLC
• Final material fully characterized for structure and trace contaminants

Final product types

• Pharmaceutical impurity reference standards (certified, characterized)
• Isotopically labeled impurity markers for process validation
• Analytical control standards for regulatory dossier support